July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
David Pinato: Immunotherapy might become a novel standard of care in intermediate-stage HCC
Apr 10, 2024, 09:52

David Pinato: Immunotherapy might become a novel standard of care in intermediate-stage HCC

David Pinato, Director of Developmental Cancer Therapeutics at Imperial College London, shared on LinkedIn:

“Immunotherapy might become a novel standard of care in intermediate-stage HCC.

PETAL is the first study to focus on mechanisms of synergy between TACE and PD-1 inhibition at Imperial College London.”

Proceed to the article.
Source: David Pinato/LinkedIn